<!DOCTYPE html><html lang="en"><head><meta charset="UTF-8"><meta name="viewport" content="width=device-width,initial-scale=1.0"><title>Osteoporosis &amp; Bone Health — SugarWise</title><link rel="stylesheet" href="styles.css"></head><body>
<nav class="navbar"><div class="navbar-inner"><a class="brand" href="index.html">SugarWise</a><a class="home-link" href="index.html">All Topics</a></div></nav>
<div class="container">
<div class="page-header"><h1>Osteoporosis &amp; Bone Health</h1><p>Understanding and preventing bone disease in people with diabetes</p></div>
<div class="last-reviewed">Content last reviewed: January 2026 | AI-assisted content</div>

<!-- Animated SVG Bone -->
<div style="text-align:center;margin:2rem 0">
<svg width="200" height="200" viewBox="0 0 200 200" xmlns="http://www.w3.org/2000/svg">
  <ellipse cx="70" cy="50" rx="25" ry="18" fill="#f5f0e8" stroke="#bfaa8c" stroke-width="2"/>
  <ellipse cx="130" cy="50" rx="25" ry="18" fill="#f5f0e8" stroke="#bfaa8c" stroke-width="2"/>
  <rect x="85" y="45" width="30" height="110" rx="8" fill="#f5f0e8" stroke="#bfaa8c" stroke-width="2"/>
  <ellipse cx="70" cy="155" rx="25" ry="18" fill="#f5f0e8" stroke="#bfaa8c" stroke-width="2"/>
  <ellipse cx="130" cy="155" rx="25" ry="18" fill="#f5f0e8" stroke="#bfaa8c" stroke-width="2"/>
  <!-- Pulsing circles representing bone loss -->
  <circle cx="100" cy="80" r="5" fill="#e74c3c" opacity="0.6"><animate attributeName="r" values="3;8;3" dur="2s" repeatCount="indefinite"/><animate attributeName="opacity" values="0.8;0.2;0.8" dur="2s" repeatCount="indefinite"/></circle>
  <circle cx="95" cy="110" r="4" fill="#e74c3c" opacity="0.5"><animate attributeName="r" values="2;6;2" dur="2.5s" repeatCount="indefinite"/><animate attributeName="opacity" values="0.7;0.2;0.7" dur="2.5s" repeatCount="indefinite"/></circle>
  <circle cx="105" cy="130" r="4" fill="#e74c3c" opacity="0.5"><animate attributeName="r" values="2;7;2" dur="1.8s" repeatCount="indefinite"/><animate attributeName="opacity" values="0.6;0.2;0.6" dur="1.8s" repeatCount="indefinite"/></circle>
  <text x="100" y="195" text-anchor="middle" font-size="11" fill="#888">Bone weakening in diabetes</text>
</svg>
</div>

<h2><span class="icon-sm">&#x1F9B4;</span> How Diabetes Affects Bones</h2>
<p>The relationship between diabetes and bone health is complex and differs between Type 1 and Type 2 diabetes:</p>

<div class="info-cards">
  <div class="info-card">
    <div class="ic-icon">
      <svg width="48" height="48" viewBox="0 0 48 48"><circle cx="24" cy="24" r="22" fill="#e3f2fd" stroke="#1976d2" stroke-width="2"/><text x="24" y="29" text-anchor="middle" font-size="14" font-weight="bold" fill="#1976d2">T1D</text></svg>
    </div>
    <div class="ic-title">Type 1 Diabetes</div>
    <div class="ic-text"><strong>Lower bone mineral density (BMD).</strong> Insulin is an anabolic hormone that promotes bone formation. In T1D, insulin deficiency from onset leads to reduced bone mass, especially if diagnosed in childhood when peak bone mass is being established. Fracture risk is 6–7 times higher than non-diabetics. Hip fracture risk is particularly elevated.</div>
  </div>
  <div class="info-card">
    <div class="ic-icon">
      <svg width="48" height="48" viewBox="0 0 48 48"><circle cx="24" cy="24" r="22" fill="#fff3e0" stroke="#ef6c00" stroke-width="2"/><text x="24" y="29" text-anchor="middle" font-size="14" font-weight="bold" fill="#ef6c00">T2D</text></svg>
    </div>
    <div class="ic-title">Type 2 Diabetes</div>
    <div class="ic-text"><strong>Normal or even high BMD, but poor bone quality.</strong> This is the paradox — T2D patients often have normal DEXA scan results yet still fracture more frequently (1.3–1.7x higher risk). The problem is microarchitectural deterioration: advanced glycation end products (AGEs) accumulate in collagen fibers, making bones stiff and brittle, like a dry twig that snaps easily despite appearing thick.</div>
  </div>
  <div class="info-card">
    <div class="ic-icon">
      <svg width="48" height="48" viewBox="0 0 48 48"><circle cx="24" cy="24" r="22" fill="#fce4ec" stroke="#c62828" stroke-width="2"/><text x="24" y="29" text-anchor="middle" font-size="16" fill="#c62828">&#x26A0;</text></svg>
    </div>
    <div class="ic-title">The Hidden Risk</div>
    <div class="ic-text">Standard DEXA scans <strong>underestimate fracture risk in T2D</strong> because they measure density, not quality. A T2D patient with a "normal" T-score of -1.0 may actually have the same fracture risk as a non-diabetic with a T-score of -2.5 (osteoporosis range). FRAX scores should be adjusted upward for T2D patients.</div>
  </div>
</div>

<h2><span class="icon-sm">&#x1F48A;</span> Diabetes Medications &amp; Bone Health</h2>

<div class="table-responsive">
<table class="data-table">
<thead>
<tr><th>Medication</th><th>Effect on Bones</th><th>Clinical Implication</th></tr>
</thead>
<tbody>
<tr><td><strong>Metformin</strong></td><td style="color:#27ae60">Bone-neutral to mildly protective</td><td>May stimulate osteoblast activity. Safe from a bone perspective. Preferred first-line drug.</td></tr>
<tr><td><strong>Pioglitazone (TZD)</strong></td><td style="color:#e74c3c"><strong>Reduces bone density</strong></td><td>Activates PPAR-gamma, which diverts stem cells toward fat cells instead of bone-forming osteoblasts. Increases fracture risk by 30&ndash;50%, especially in postmenopausal individuals. <strong>Avoid in anyone with osteoporosis risk.</strong></td></tr>
<tr><td><strong>Canagliflozin (SGLT2i)</strong></td><td style="color:#e67e22">Possible increased fracture risk</td><td>Canagliflozin specifically showed increased fracture risk in the CANVAS trial. Empagliflozin and dapagliflozin appear safer. Mechanism may involve phosphate-calcium balance disruption.</td></tr>
<tr><td><strong>Insulin</strong></td><td style="color:#27ae60">Bone-neutral (may be anabolic)</td><td>Insulin promotes bone formation. However, hypoglycemia from insulin causes falls, which cause fractures — an indirect risk.</td></tr>
<tr><td><strong>DPP-4 Inhibitors</strong></td><td style="color:#27ae60">Bone-neutral</td><td>No significant effect on bone metabolism. Safe choice for patients with bone health concerns.</td></tr>
<tr><td><strong>GLP-1 Receptor Agonists</strong></td><td style="color:#27ae60">Bone-neutral to mildly protective</td><td>GLP-1 receptors exist on bone cells. May have mild beneficial effects. No increased fracture risk demonstrated.</td></tr>
<tr><td><strong>Sulfonylureas</strong></td><td style="color:#f39c12">Indirect risk (hypoglycemia → falls)</td><td>No direct bone effect, but hypoglycemia-induced falls are a significant fracture risk factor in older adults.</td></tr>
</tbody>
</table>
</div>

<h2><span class="icon-sm">&#x1F3AF;</span> Daily Calcium &amp; Vitamin D Targets</h2>
<p>Calcium and vitamin D are the foundation of bone health. Most Indians — especially those on vegetarian diets — are severely deficient in both.</p>

<div style="display:flex;flex-wrap:wrap;justify-content:center;gap:2rem;margin:2rem 0">
  <!-- Calcium Gauge -->
  <div style="text-align:center">
    <svg width="160" height="160" viewBox="0 0 160 160">
      <circle cx="80" cy="80" r="70" fill="none" stroke="#e0e0e0" stroke-width="10"/>
      <circle cx="80" cy="80" r="70" fill="none" stroke="#1976d2" stroke-width="10" stroke-dasharray="440" stroke-dashoffset="440" stroke-linecap="round" transform="rotate(-90 80 80)">
        <animate attributeName="stroke-dashoffset" from="440" to="110" dur="1.5s" fill="freeze" begin="0.5s"/>
      </circle>
      <text x="80" y="72" text-anchor="middle" font-size="22" font-weight="bold" fill="#1976d2">1000</text>
      <text x="80" y="92" text-anchor="middle" font-size="11" fill="#555">–1200 mg/day</text>
      <text x="80" y="110" text-anchor="middle" font-size="12" fill="#888">Calcium</text>
    </svg>
    <p style="font-size:0.85rem;max-width:180px;margin:0 auto">From diet + supplements combined. Split doses for better absorption.</p>
  </div>
  <!-- Vitamin D Gauge -->
  <div style="text-align:center">
    <svg width="160" height="160" viewBox="0 0 160 160">
      <circle cx="80" cy="80" r="70" fill="none" stroke="#e0e0e0" stroke-width="10"/>
      <circle cx="80" cy="80" r="70" fill="none" stroke="#f39c12" stroke-width="10" stroke-dasharray="440" stroke-dashoffset="440" stroke-linecap="round" transform="rotate(-90 80 80)">
        <animate attributeName="stroke-dashoffset" from="440" to="176" dur="1.5s" fill="freeze" begin="0.8s"/>
      </circle>
      <text x="80" y="72" text-anchor="middle" font-size="22" font-weight="bold" fill="#f39c12">1000</text>
      <text x="80" y="92" text-anchor="middle" font-size="11" fill="#555">–2000 IU/day</text>
      <text x="80" y="110" text-anchor="middle" font-size="12" fill="#888">Vitamin D</text>
    </svg>
    <p style="font-size:0.85rem;max-width:180px;margin:0 auto">Target serum 25(OH)D: 30–50 ng/mL. Higher doses if deficient.</p>
  </div>
  <!-- Protein Gauge -->
  <div style="text-align:center">
    <svg width="160" height="160" viewBox="0 0 160 160">
      <circle cx="80" cy="80" r="70" fill="none" stroke="#e0e0e0" stroke-width="10"/>
      <circle cx="80" cy="80" r="70" fill="none" stroke="#27ae60" stroke-width="10" stroke-dasharray="440" stroke-dashoffset="440" stroke-linecap="round" transform="rotate(-90 80 80)">
        <animate attributeName="stroke-dashoffset" from="440" to="220" dur="1.5s" fill="freeze" begin="1.1s"/>
      </circle>
      <text x="80" y="72" text-anchor="middle" font-size="22" font-weight="bold" fill="#27ae60">1.0</text>
      <text x="80" y="92" text-anchor="middle" font-size="11" fill="#555">–1.2 g/kg/day</text>
      <text x="80" y="110" text-anchor="middle" font-size="12" fill="#888">Protein</text>
    </svg>
    <p style="font-size:0.85rem;max-width:180px;margin:0 auto">Adequate protein is essential for bone matrix. Include dairy, eggs, lentils, paneer.</p>
  </div>
</div>

<h2><span class="icon-sm">&#x26A0;</span> Risk Factors — Especially in the Indian Population</h2>

<div class="info-cards">
  <div class="info-card">
    <div class="ic-icon">
      <svg width="48" height="48" viewBox="0 0 48 48"><circle cx="24" cy="24" r="22" fill="#fce4ec" stroke="#c62828" stroke-width="2"/><text x="24" y="29" text-anchor="middle" font-size="16" fill="#c62828">&#x26A0;</text></svg>
    </div>
    <div class="ic-title">Postmenopausal Status</div>
    <div class="ic-text">Estrogen protects bones. After menopause, bone mass loss of 2&ndash;3% per year occurs for 5&ndash;7 years. In India, menopause tends to occur earlier (average 46&ndash;48 years vs. 51 in the West), giving more years of bone loss.</div>
  </div>
  <div class="info-card">
    <div class="ic-icon">
      <svg width="48" height="48" viewBox="0 0 48 48"><circle cx="24" cy="24" r="22" fill="#fff3e0" stroke="#ef6c00" stroke-width="2"/><text x="24" y="29" text-anchor="middle" font-size="14" fill="#ef6c00">Vit D</text></svg>
    </div>
    <div class="ic-title">Vitamin D Deficiency</div>
    <div class="ic-text">70–90% of Indians are vitamin D deficient despite abundant sunlight. Cultural practices (covering skin, staying indoors), darker skin pigmentation, and pollution reduce synthesis. Urban Indians are more deficient than rural populations.</div>
  </div>
  <div class="info-card">
    <div class="ic-icon">
      <svg width="48" height="48" viewBox="0 0 48 48"><circle cx="24" cy="24" r="22" fill="#e8f5e9" stroke="#27ae60" stroke-width="2"/><text x="24" y="29" text-anchor="middle" font-size="14" fill="#27ae60">Ca&#x2193;</text></svg>
    </div>
    <div class="ic-title">Low Calcium Intake</div>
    <div class="ic-text">Average dietary calcium intake in India is only 400–500 mg/day — less than half the recommended 1000–1200 mg. Lactose intolerance, vegetarian diets without adequate dairy, and low consumption of calcium-rich greens contribute to this gap.</div>
  </div>
  <div class="info-card">
    <div class="ic-icon">
      <svg width="48" height="48" viewBox="0 0 48 48"><circle cx="24" cy="24" r="22" fill="#e3f2fd" stroke="#1565c0" stroke-width="2"/><text x="24" y="29" text-anchor="middle" font-size="14" fill="#1565c0">BMI</text></svg>
    </div>
    <div class="ic-title">Small Body Frame</div>
    <div class="ic-text">Indian populations tend to have smaller body frames and lower peak bone mass compared to Western populations. Starting with lower bone reserves means the osteoporosis threshold is reached sooner with age-related loss.</div>
  </div>
  <div class="info-card">
    <div class="ic-icon">
      <svg width="48" height="48" viewBox="0 0 48 48"><circle cx="24" cy="24" r="22" fill="#f3e5f5" stroke="#7b1fa2" stroke-width="2"/><text x="24" y="29" text-anchor="middle" font-size="14" fill="#7b1fa2">&#x1F3E0;</text></svg>
    </div>
    <div class="ic-title">Sedentary Lifestyle</div>
    <div class="ic-text">Physical inactivity is a major modifiable risk factor. Weight-bearing exercise stimulates bone formation. Many older Indians are physically inactive, particularly in urban settings, accelerating bone loss.</div>
  </div>
  <div class="info-card">
    <div class="ic-icon">
      <svg width="48" height="48" viewBox="0 0 48 48"><circle cx="24" cy="24" r="22" fill="#fff8e1" stroke="#f9a825" stroke-width="2"/><text x="24" y="29" text-anchor="middle" font-size="14" fill="#f9a825">TZD</text></svg>
    </div>
    <div class="ic-title">Pioglitazone Use</div>
    <div class="ic-text">Pioglitazone is widely prescribed in India for T2D. In postmenopausal individuals already at bone risk, it further accelerates bone loss. Discuss alternatives (DPP-4i, SGLT2i) with your doctor if you have bone health concerns.</div>
  </div>
</div>

<h2><span class="icon-sm">&#x1F4CA;</span> DEXA Scan Screening</h2>
<p>A DEXA (Dual-Energy X-ray Absorptiometry) scan measures bone mineral density at the hip and spine. The result is reported as a <strong>T-score</strong>:</p>
<ul>
<li><strong>T-score ≥ -1.0:</strong> Normal bone density</li>
<li><strong>T-score -1.0 to -2.5:</strong> Osteopenia (low bone mass, pre-osteoporosis)</li>
<li><strong>T-score ≤ -2.5:</strong> Osteoporosis</li>
</ul>
<p><strong>Who should be screened:</strong></p>
<ul>
<li>All people assigned female at birth aged 65+ and assigned male at birth aged 70+</li>
<li>Postmenopausal individuals under 65 with risk factors (diabetes, low BMI, family history, smoking)</li>
<li>Anyone with Type 1 diabetes (at any age, after skeletal maturity)</li>
<li>Anyone on pioglitazone or long-term corticosteroids</li>
<li>Anyone with a fragility fracture (fracture from a fall from standing height or less)</li>
</ul>
<p><strong>Remember:</strong> For Type 2 diabetes patients, a "normal" DEXA result does not rule out high fracture risk. Use the FRAX tool with the "rheumatoid arthritis" option checked as a proxy to adjust for the elevated risk in T2D.</p>

<h2><span class="icon-sm">&#x1F3CB;</span> Weight-Bearing Exercise for Bone Health</h2>
<p>Exercise is one of the most effective non-pharmacological interventions for bone health. The key principle is that bones strengthen in response to mechanical loading:</p>
<ul>
<li><strong>Weight-bearing aerobic:</strong> Brisk walking, jogging, dancing, stair climbing — at least 30 minutes, 5 days/week.</li>
<li><strong>Resistance training:</strong> Squats, lunges, resistance bands, light weights — 2–3 sessions/week. Particularly effective for hip and spine bone density.</li>
<li><strong>Balance and flexibility:</strong> Yoga, tai chi, single-leg stands — reduces fall risk by 30–40%. Critical for older adults.</li>
<li><strong>Avoid high-impact activities</strong> if osteoporosis is already established (risk of fracture). Swimming and cycling are low-impact but do not improve bone density as effectively.</li>
</ul>

<h2><span class="icon-sm">&#x1F6E1;</span> Fall Prevention</h2>
<p>In older adults, preventing falls is as important as strengthening bones. Key strategies:</p>
<ul>
<li>Remove loose rugs, ensure adequate lighting in corridors and bathrooms.</li>
<li>Install grab bars in bathrooms and handrails on stairs.</li>
<li>Wear non-slip footwear indoors and outdoors.</li>
<li>Review medications that cause dizziness (beta-blockers, diuretics, sedatives, alpha-blockers).</li>
<li>Correct vision problems — get annual eye exams.</li>
<li>Avoid hypoglycemia — the most common diabetes-related cause of falls.</li>
<li>Treat orthostatic hypotension — rise slowly from sitting/lying positions.</li>
</ul>

<h2><span class="icon-sm">&#x1F48A;</span> Osteoporosis Medications</h2>
<p>When lifestyle measures are insufficient, pharmacological treatment may be needed:</p>
<ul>
<li><strong>Bisphosphonates (alendronate, risedronate, zoledronic acid):</strong> First-line therapy. Reduce fracture risk by 40–70%. Alendronate is taken weekly on an empty stomach, remaining upright for 30 minutes. Zoledronic acid is given as an annual IV infusion.</li>
<li><strong>Denosumab:</strong> A biologic injection given every 6 months. Effective for severe osteoporosis. Must not be stopped abruptly — rebound bone loss can occur.</li>
<li><strong>Teriparatide:</strong> A bone-building (anabolic) daily injection for severe osteoporosis. Limited to 2 years of use. Expensive but highly effective.</li>
<li><strong>Raloxifene:</strong> A selective estrogen receptor modulator for postmenopausal individuals. Reduces spine fractures but not hip fractures. Also reduces breast cancer risk.</li>
</ul>

<div class="page-nav">
<a class="prev" href="liver-health.html">Liver Health</a>
<a class="next" href="hearing-loss.html">Hearing Loss</a>
</div>
</div>
<div class="disclaimer">This content is for educational purposes only and does not replace professional medical advice. The creators of SugarWise are not medical professionals. Do not start, stop, or change any medication without consulting your doctor. In case of emergency, call 112 (India) or your local emergency number. <a href="terms-of-use.html">Read full Terms of Use &amp; Medical Disclaimer</a></div>
<div class="privacy-notice">SugarWise does not use cookies, collect personal data, or track users.</div>
<div class="footer"><span class="ai-badge">AI-Assisted Content</span><br>SugarWise &bull; Comprehensive Diabetes Management Companion &bull; <a href="terms-of-use.html">Terms of Use</a> &bull; Last updated: January 2026</div>
<button class="scroll-top" id="scrollTop" title="Back to top">&uarr;</button>
<script>
var sb=document.getElementById('scrollTop');window.addEventListener('scroll',function(){sb.classList.toggle('visible',window.scrollY>400)});sb.addEventListener('click',function(){window.scrollTo({top:0,behavior:'smooth'})});
document.querySelectorAll('.accordion-header').forEach(function(h){h.addEventListener('click',function(){this.parentElement.classList.toggle('open')})});
</script>
</body></html>